Antinociceptive mechanism of L-DOPA

Pain

Volumn 110, Issue 1-2, 2004, Pages 246-249

  Shimizu, Takao ^a   Iwata, Shin Ichi ^a   Morioka, Hirofumi ^a   Masuyama, Takasi ^a   Fukuda, Takeo ^a   Nomoto, Masahiro ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b EHIME UNIVERSITY   (Japan)

Author keywords

D2 receptor; Dopamine; L DOPA; Substance P

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BENSERAZIDE; LEVODOPA; SUBSTANCE P; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BEHAVIOR, ANIMAL; BENSERAZIDE; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; INJECTIONS, SPINAL; LEVODOPA; MALE; MICE; PAIN; PAIN MEASUREMENT; SPINAL CORD; SUBSTANCE P; TIME FACTORS;

EID: 3242718704     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2004.03.038     Document Type: Article

References (26)

1. Barasi S., Duggal K.N. The effect of local and systemic application of dopaminergic agents on tail flick latency in the rat. Eur J Pharmacol. 117:1985;287-294
2. Barasi S., Ben-Sreti M.M., Clatworthy A.L., Duggal K.N., Gonzalez J.P., Robertson J., Rooney K.F., Sewell R.D. Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390. Br J Pharmacol. 90:1987;15-22
3. Chen J.F., Qin Z.H., Szele F., Bai G., Weiss B. Neuronal localization and modulation of the D2 dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamine. Neuropharmacology. 30:1991;927-941
4. Coggeshall R.E., Carlton S.M. Receptor localization in the mammalian dorsal horn and primary afferent neurons. Brain Res Brain Res Rev. 24:1997;28-66
5. Dickey R.P., Minton J.P. Levodopa relief of bone pain from breast cancer. N Engl J Med. 286:1972;843
6. Dubois A., Savasta M., Curet O., Scatton B. Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors. Neuroscience. 19:1986;125-137
7. Ertas M., Sagduyu A., Arac N., Uludag B., Ertekin C. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain. 75:1998;257-259
8. Ford B. Pain in Parkinson's disease. Clin Neurosci. 5:1998;63-72
9. Hökfelt T., Phillipson O., Goldstein M. Evidence for a dopaminergic pathway in the rat descending from the A11 cell group to the spinal cord. Acta Physiol Scand. 107:1979;393-395
10. Hylden J.L., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur J Pharmacol. 67:1980;313-316
11. Hylden J.L., Wilcox G.L. Intrathecal substance P elicits a caudally-directed biting and scratching behaviors in mice. Brain Res. 217:1981;212-215
12. Iwata S., Izumi K., Nomoto M. Upregulation of postsynaptic dopamine receptors in the striatum does not influence haloperidol-induced catalepsy in mice. Pharmacol Biochem Behav. 42:1992;803-808
13. Jensen T.S., Smith D.F. Dopaminergic effects on tail-flick response in spinal rats. Eur J Pharmacol. 79:1982;129-133
14. Jensen T.S., Yaksh T.L. Effects of an intrathecal dopamine agonist, apomorphine, on thermal and chemical evoked noxious responses in rats. Brain Res. 296:1984;285-293
15. Jones S.L. Descending noradrenergic influence on pain. Pompeiano O. Progress in Brain Research vol. 88. 1991;381-394 Elsevier, Amsterdam
16. Ko M.L., King M.A., Gordon T.L., Crisp T. The effects of aging on spinal neurochemistry in the rat. Brain Res Bull. 42:1997;95-98
17. Kernbaum S., Hauchecorne J. Administration of levodopa for relief of herpes zoster pain. J Am Med Assoc. 246:1981;132-134
18. Liu Q.S., Qiao J.T., Dafny N. D2 dopamine receptor involvement in spinal dopamine-produced antinociception. Life Sci. 51:1992;1485-1492
19. Nixon D.W. Letter: Use of L-dopa to relieve pain from bone metastases. N Engl J Med. 292:1975;647
20. Paalzow G.H. L-dopa induces opposing effects on pain in intact rats: (-)-sulpiride, SCH 23390 or alpha-methyl-DL-p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses. J Pharmacol Exp Ther. 263:1992;470-479
21. Quinn N.P., Koller W.C., Lang A.E., Marsden C.D. Painful Parkinson's disease. Lancet. 1:1986;1366-1369
22. Sage J.I., Kortis H.I., Sommer W. Evidence for the role of spinal cord systems in Parkinson's disease-associated pain. Clin Neuropharmacol. 13:1990;171-174
23. Sandyk R., Bamford C.R., Iacono R.P. Pain and sensory symptoms in Parkinson's disease. Int J Neurosci. 39:1988;15-25
24. Skagerberg G., Björklund A., Lindvall O., Schmidt R.H. Origin and termination of the diencephalo-spinal dopamine system in the rat. Brain Res Bull. 9:1982;237-244
25. Snider S.R., Fahn S., Isgreen W.P., Cote L.J. Primary sensory symptoms in parkinsonism. Neurology. 26:1976;423-429
26. Yokoyama C., Okamura H., Nakajima T., Taguchi J., Ibata Y. Autoradiographic distribution of [3H]YM-09151-2, a high-affinity and selective antagonist ligand for the dopamine D2 receptor group, in the rat brain and spinal cord. J Comp Neurol. 344:1994;121-136